Hmm
September is supposed to be the time for a strategic update.
If no new macro plans are tabled and only micro pre-clinical and very early stage stuff, it will just start to look like a way to drag things out and preserve the income stream of management. $80m of burn will give them a good 4 years or so of nothingness to work on.
LANI positive results, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)